Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).
Mahalingam D, Chen S, Xie P, Loghmani H, Heineman T, Kalyan A, Kircher S, Helenowski IB, Mi X, Maurer V, Coffey M, Mulcahy M, Benson A, Zhang B.
Mahalingam D, et al. Among authors: benson a.
Br J Cancer. 2023 Sep;129(5):782-790. doi: 10.1038/s41416-023-02344-5. Epub 2023 Jul 13.
Br J Cancer. 2023.
PMID: 37443348
Free PMC article.